Pulmotect, Inc.
  • Home
  • About Us
    • Our Company
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
  • Our Approach
    • Overview
    • Our Science
    • Our Pipeline
    • Published Journal Articles
  • News
  • Contact Us

Pulmotect Announces Initial Close on $12 Million Series B

Posted on May 9, 2018 by Brenton Scott
Posted in Press Releases

Post navigation

Pulmotect Seeks Quick-To-Market Path For Rapid-Acting Respiratory Drug
AstraZeneca VP Kumar Srinivasan Joins Pulmotect, Inc. Board of Directors
Pulmotect Inc

3900 Essex Ln, Suite 575
Houston, TX 77027
Contact Us

© 2023
Pulmotect, Inc.